ACTRN12620000882921尚未招募未知
Observational study investigating appropriateness of discharge analgesia prescribing and analgesic outcomes in elective and emergency surgical patients after discharge in Southern Adelaide Local Health Network: A prospective pilot study
Flinders Medical Centre - Department of Anaesthesia0 个研究点目标入组 400 人开始时间: 2020年9月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Undergoing elective or emergency surgery at Flinders Medical Centre or Noarlunga Health Service.
- •-Aged 18 years or greater at time of consent.
排除标准
- •-Unable to provide informed consent for self (as per consent to surgery).
- •-Self identifies as being unable to complete an online survey on their smart phone.
- •-Non-English speaking.
- •-Declines participation.
研究者
相似试验
尚未招募
不适用
Observational study to evaluate the acceptability and bleeding profile with Drospirenone 4 mg, in a regimen of use 24/4 in contraception (Slinda®) including patient who have been taken Slinda® for at least 5 cycles of use during breastfeeding. BreastSlinda® Study.DRKS00028438Exeltis Poland Sp.zo.o.100
已完成
不适用
Prospective observational study to evaluate appropriate dosage and efficacy of cephamycin and oxacephem for invasive UTI due to ESBL-E. coliinvasive UTIJPRN-UMIN000041639CGM78
招募中
不适用
Coronary Artery Disease Risk Markers StudyCTRI/2022/03/041076Current Medical Concepts Private Limited
已完成
不适用
Effect of Ferric carboxymaltose in patients with Chronic Heart failure with Iron deficiency anaemiaCTRI/2021/02/031307Emcure Pharmaceuticals Limited98
尚未招募
不适用
Observational study to evaluate acceptability and bleeding profile with Drospirenone 4 mg, in a regimen of use 24/4 in contraception (Slinda®, Exeltis HealthCare) after six months of use.Z30Contraceptive managementDRKS00025993Exeltis Healthcare300